Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cardiac Blood Test Predicts Post-Operative Complications

By HospiMedica International staff writers
Posted on 06 Jan 2020
A new study suggests that preoperative measurement of N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) can predict adverse outcomes after most types of surgery.

Researchers from nine countries, including the University of Montreal (Canada), McMaster University (Hamilton, ON, Canada), Hospital Israelita Albert Einstein (São Paulo, Brazil), and other institutions conducted a cohort study to examine if higher pre-operative levels of NT-proBNP can predict post-surgical cardiac and vascular complications. More...
The study included 10,402 patients (45 years of age or older) undergoing non-cardiac surgery. All patients had NT-proBNP levels measured before surgery and troponin T levels measured daily for up to three days after surgery.

The results showed that compared with patients with preoperative NT-proBNP values less than 100 pg/mL, patients with levels of 100-200 pg/mL, 200-1,500 pg/mL, and 1500 pg/mL or greater were associated with adjusted hazard ratios of 2.27, 3.63, and 5.82, respectively. Corresponding incidences of the composite of vascular death and myocardial injury after noncardiac surgery (MINS) were 12.3% , 20.8%, and 37.5%, respectively. Preoperative NT-proBNP values were also significantly associated with 30-day all-cause mortality. The study was published on December 24, 2109, in Annals of Internal Medicine.

"Any type of surgery has the potential to cause damage to heart tissue, through blood clot formation, long periods of inflammation, or bleeding,” said senior author cardiologist Professor PJ Deveraux, MD, of McMaster University, and the Population Health Research Institute (PHRI; Hamilton, Ontario, Canada). “As a result of these findings, doctors can predict who is at greater risk of heart attacks and other negative vascular events after surgery.”

“This simple blood test can be done quickly and easily as part of patient's pre-operative evaluation, and can help patients better understand their risk of post-operative complications and make informed decisions about their surgery,” said lead author Emmanuelle Duceppe, MD, of the Centre Hospitalier de l'Universite de Montreal (CHUM; Canada), and associate researcher at PHRI. “This blood test is twenty times cheaper than more time-consuming tests such as cardiac stress tests and diagnostic imaging.”

NT-proBNP is a non-active prohormone that is released from the same molecule that produces B-type natriuretic peptide (BNP). Both BNP and NT-proBNP are released in response to changes in pressure inside the heart that are associated with heart failure (HF) and other cardiac problems. Normal levels of NT-proBNP are lower than 125 pg/mL for patients aged up to 74 years, and less than 450 pg/mL for patients aged 75-99 years.

Related Links:
University of Montreal
McMaster University
Hospital Israelita Albert Einstein



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.